People on the Move
Biocon
Biocon, the Bangalore-based biopharmaceutical company, has announced the appointment of Arun Chandacarkar (pictured) as CEO and joint MD of the company. He joins on the board of directors the Chairman and MD, Kiran Mazumdar-Shaw.
Chandavarkar has worked as Chief Operating Officer of Biocon since 2006, and before that as general operations manager since 1990.
Biocon was recently forced to defend the high price of its newly launched trastuzamab biosimilar, saying it would be sold at 25% less than its reference product, Roche’s Herceptin.
